Through its research, blogs, and commentary, Farient is driving the conversation on executive compensation and governance issues.

March 7, 2017

Bloomberg – Health Insurers Would Get Fatter Tax Break on CEO Pay Under GOP Health Plan

John Trentacoste, director at Farient Advisors, speaks to Bloomberg about the implications of the proposed bill to replace Obamacare on health insurance companies.

Read More

March 1, 2017

FCPA Blog – How perverse incentives distort individual and corporate performance

Mark Hodak, a partner at Farient Advisors, explores how even good, ethical employees can succumb to perverse incentives due to the pressure to meet internal targets.

Read More

February 21, 2017

Agenda – Boards Move to Lessen Impact of TSR, Experts Say

While the use of relative total shareholder return (TSR) has increased in recent years, there are signs that boards are nevertheless trying to lessen its impact on their long-term incentive plans. Some boards have started to de-emphasize TSR in their incentive plans, and going forward, experts say TSR usage could flatten out or even decline.

Read More

February 13, 2017

FCPA Blog – Revisiting EpiPen: Steep incentive thresholds are corporate disasters waiting to happen

Marc Hodak, partner at Farient Advisors, explains how steep incentive thresholds were behind the Epipen scandal and how companies can learn from Mylan’s mistake.

Read More

February 6, 2017

Agenda – Comp Committees Move on Refreshment

Boards are being urged to focus on refreshing their compensation committees to ensure there is the right balance of skills and experience to support the overall corporate strategy, experts say. Failure to sufficiently refresh the compensation committee over time, they say, could cause pay programs to suffer, lead to discontent among investors and even have consequences for director votes.

Read More